Related Experiment Video
Updated: Jul 9, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Correlation between haemodynamic and metabolic changes in three models of experimental cardiac hypertrophy
Insights
Cardiac hypertrophy models show distinct hemodynamic and metabolic changes. Cyclic AMP levels correlate with contractility in isoproterenol and triiodothyronine models, but not pressure-induced hypertrophy.
Area of Science:
- Cardiovascular Physiology
- Cardiac Metabolism
- Pharmacology
Background:
- Cardiac hypertrophy is a complex adaptation with varied underlying mechanisms.
- Understanding the interplay between hemodynamic changes and cellular metabolism is crucial for effective treatment strategies.
Purpose of the Study:
- To characterize three distinct models of cardiac hypertrophy (pressure overload, isoproterenol, and triiodothyronine) using hemodynamic and metabolic assessments.
- To investigate the relationship between cardiac contractility, cyclic AMP levels, and adenine nucleotide biosynthesis in these models.
Main Methods:
- Hemodynamic parameters (heart rate, left ventricular systolic pressure, maximal rate of pressure rise) were measured in closed-chest rats via left ventricular catheterization.
- Metabolic assessments included cardiac cyclic AMP levels and myocardial adenine nucleotide biosynthesis rates.
- The effect of beta-receptor blockade (propranolol) was evaluated.
Main Results:
- Aortic constriction led to decreased heart rate and increased ventricular pressure/contractility.
- Isoproterenol increased heart rate and contractility but decreased ventricular pressure.
- Triiodothyronine elevated all measured hemodynamic parameters.
- Increased contractility correlated with elevated cyclic AMP in isoproterenol and triiodothyronine models, but not pressure overload.
- Propranolol blocked adenine nucleotide biosynthesis changes in isoproterenol and triiodothyronine models, but not pressure-induced hypertrophy.
Conclusions:
- Different models of cardiac hypertrophy exhibit unique hemodynamic and metabolic profiles.
- Cyclic AMP plays a significant role in mediating contractility changes in certain hypertrophy models.
- Adenine nucleotide biosynthesis is differentially affected by beta-receptor blockade across hypertrophy models.
Abstract:
Three models of cardiac hypertrophy (aortic constriction, application of isoproterenol, daily injections of triiodothyronine) were characterized in haemodynamic and in metabolic terms. Heart function was evaluated in closed-chest rats after catheterization of the left ventricle with an ultraminiature catheter pressure transducer. Heart rate (HR), left ventricular systolic pressure (LVSP), and the maximal rate of rise of left ventricular pressure (LV dP/dtmax) were measured. The metabolic parameters determined included the levels of cardiac cyclic AMP and the rates of the biosynthesis of myocardial adenine nucleotides. During the first 72 h after aortic constriction, HR was decreased, whereas LVSP and LV dP/dtmax were both elevated. Within 12 h after administration of isoproterenol, HR and LV dP/dtmax were markedly increased, while LVSP was depressed. In triiodothyronine-treated animals, all haemodynamic parameters were elevated during the first 72 h. Comparison with the time course of changes in metabolic parameters revealed that the rise in cardiac contractility measured as LV dP/dtmax occurred at about the same time as the increase in the content of myocardial cyclic AMP in the isoproterenol- and triiodothyronine-models. In hypertrophy due to aortic constriction, cardiac cyclic AMP was elevated only moderately, and this elevation did not correlate with the enhancement of contractility. Beta-receptor-blockade with propranolol prevented entirely the increase of myocardial adenine nucleotide biosynthesis in the isoproterenol- and triiodothyronine- but not in pressure-induced hypertrophy.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

